Type I IFN receptor blockade by anifrolumab reduces cutaneous lupus in monogenic SLE

Research output: Contribution to journalLetterContributedpeer-review

Contributors

Details

Original languageEnglish
Pages (from-to)1318-1321
Number of pages4
JournalJDDG - Journal of the German Society of Dermatology
Volume23
Issue number10
Publication statusPublished - Oct 2025
Peer-reviewedYes

External IDs

PubMed 40567058
ORCID /0000-0002-4330-1861/work/203814481

Keywords

ASJC Scopus subject areas